News | November 16, 2024
IOL Chemicals and Pharmaceuticals posts Q2 FY25 PT at Rs. 19 Cr
Total Income in Q2 FY25 stood at Rs. 532.18 crore
Total Income in Q2 FY25 stood at Rs. 532.18 crore
Pharma CDMO business has posted a 40% YoY in Q2 driven by BD efforts and backed by macro tailwinds
Construction of the plant will commence in 2025 with first production expected to be in 2027
For Q2, Akums reported a consolidated total income of Rs. 1,046.6 crore
Emcure Pharmaceuticals has reported total income of Rs. 2,037.63 crores during the period ended September 30, 2024
US Generics grew 5% to Rs. 467 Crores for the quarter
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
Jagsonpal Pharmaceuticals has reported total income of Rs. 76.34 crores during the period ended September 30, 2024
Subscribe To Our Newsletter & Stay Updated
